The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma-successes and challenges.

ABSTRACT:

SUBMITTER: Oduah EI 

PROVIDER: S-EPMC9264087 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature